Skip to Content

Tag: Diabetic Foot Ulcers


EO2 on ADA decision: ‘It’s a big deal’

March 24, 2023Liz Beaulieu, Editor

SAN ANTONIO – EO2 Concepts believes the American Diabetes Association’s recent recommendation of continuous diffusion of oxygen (CDO) therapy as a “standard of care” for the treatment of diabetic foot ulcers will improve that therapy’s chances of being paid for more widely.  Dave Kazynski, who leads sales and marketing efforts for EO2, says the company’s CDO device, the OxyGeni, is cleared by the Food and Drug Administration and is listed as DME under code...

Diabetic Foot Ulcers, E02, Wound Care

Read Full Articlered right arrow icon